IRVINE, Calif.--(BUSINESS WIRE)--TherOx, Inc., a privately held medical device company focused on improving treatment of acute myocardial infarction (AMI), announced that the U.S. Food and Drug ...

TCT 586: Outcomes and institutional variation in arterial access choice among patients with acute myocardial infarction and cardiogenic shock undergoing PCI: An analysis from the CathPCI Registry.

Study Evaluates the Effectiveness of TherOx Supersaturated Oxygen (SSO 2) Therapy in Patients Presenting with Acute Anterior Myocardial Infarction with Successful Reperfusion Compared to Standard ...

A number of substudies have been published in 2007, including a Focus Issue of JACC highlighting additional findings from ExTRACT-TIMI 25. In ExTRACT-TIMI 25, women presented with a profile of higher ...

Vancouver, British Columbia, Canada—Poor functional outcomes after a heart attack can be predicted with a new PET imaging agent, 68 Ga-FAPI-46. According to research presented at the Society of ...

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below: Consultant Fee/Honoraria/Speaker’s Bureau ...

Most trials that have shown a benefit of beta-blocker treatment after myocardial infarction included patients with large myocardial infarctions and were conducted in an era before modern ...

Figure 3: Example of 68-year-old male patient with anterior ST-segment elevation myocardial infarction and subsequent revascularization. Molecular imaging results are given as short axis and polar map ...

Myocardial ischemia is a drop in blood flow to the heart. Myocardial infarction, or heart attack, occurs when death or damage occurs in the muscle tissue of the heart due to low blood supply. The ...

A team of scientists from Iran has recently estimated the prevalence of coronavirus disease 2019 (COVID-19) in myocardial infarction patients receiving a primary percutaneous coronary intervention. A ...